Skip to results
Modify your search
NARROW
1-16 of 16
Authors: Sumanta Pal
Journal Article
68 Use of artificial intelligence to derive International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) elements from unstructured medical records
The Oncologist, Volume 29, Issue Supplement_1, September 2024, Pages S34–S35, https://doi.org/10.1093/oncolo/oyae181.055
Published: 05 August 2024
Journal Article
72 Impact of microbiome modulation on serum cytokine profile in a randomized, phase I trial of cabozantinib/nivolumab (cabo/nivo) with or without CBM588 in pts with metastatic renal cell carcinoma (mRCC)
The Oncologist, Volume 29, Issue Supplement_1, September 2024, Pages S36–S37, https://doi.org/10.1093/oncolo/oyae181.059
Published: 05 August 2024
Journal Article
12 Concordance Analysis of Tissue and Circulating Tumor DNA (ctDNA) in Renal Cell Carcinoma (RCC): Insights from a Multimodal Real-World Database
The Oncologist, Volume 29, Issue Supplement_1, September 2024, Pages S6–S7, https://doi.org/10.1093/oncolo/oyae181.011
Published: 05 August 2024
Journal Article
69 Adherence to the ASCO Language of Respect guidelines in renal cell carcinoma abstracts in an international oncology meeting
The Oncologist, Volume 29, Issue Supplement_1, September 2024, Page S35, https://doi.org/10.1093/oncolo/oyae181.056
Published: 05 August 2024
Journal Article
35 Efficacy of treatments post-lenvatinib in patients with advanced renal cell carcinoma (aRCC)
The Oncologist, Volume 29, Issue Supplement_1, September 2024, Page S22, https://doi.org/10.1093/oncolo/oyae181.036
Published: 05 August 2024
Journal Article
The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
The Oncologist, Volume 28, Issue Supplement_1, September 2023, Pages S5–S6, https://doi.org/10.1093/oncolo/oyad216.008
Published: 23 August 2023
Journal Article
OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)
The Oncologist, Volume 28, Issue Supplement_1, September 2023, Page S14, https://doi.org/10.1093/oncolo/oyad216.023
Published: 23 August 2023
Journal Article
Patients’ Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19
The Oncologist, Volume 28, Issue 6, June 2023, Pages 494–500, https://doi.org/10.1093/oncolo/oyad028
Published: 14 March 2023
Journal Article
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
The Oncologist, Volume 28, Issue 8, August 2023, Pages 699–705, https://doi.org/10.1093/oncolo/oyad036
Published: 08 March 2023
Journal Article
Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma
The Oncologist, Volume 28, Issue 1, January 2023, Pages 59–71, https://doi.org/10.1093/oncolo/oyac142
Published: 18 January 2023
Journal Article
Recall of Genomic Testing Results Among Patients with Cancer
The Oncologist, Volume 26, Issue 12, December 2021, Pages e2302–e2305, https://doi.org/10.1002/onco.13928
Published: 26 August 2021
Journal Article
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)
The Oncologist, Volume 26, Issue 7, July 2021, Pages 560–e1103, https://doi.org/10.1002/onco.13777
Published: 29 April 2021
Journal Article
Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer
The Oncologist, Volume 25, Issue 8, August 2020, Pages 680–688, https://doi.org/10.1634/theoncologist.2019-0851
Published: 13 May 2020
Journal Article
The Impact of Cisplatin‐ or Non‐Cisplatin‐Containing Chemotherapy on Long‐Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer
The Oncologist, Volume 24, Issue 10, October 2019, Pages 1348–1355, https://doi.org/10.1634/theoncologist.2018-0739
Published: 01 April 2019
Journal Article
ALK Fusions in a Wide Variety of Tumor Types Respond to Anti‐ALK Targeted Therapy
The Oncologist, Volume 22, Issue 12, December 2017, Pages 1444–1450, https://doi.org/10.1634/theoncologist.2016-0488
Published: 04 December 2017
Journal Article
Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Trastuzumab in Older Adults with HER-2+ Breast Cancer: A Survey of Oncologists
The Oncologist, Volume 14, Issue 9, September 2009, Pages 883–890, https://doi.org/10.1634/theoncologist.2009-0056
Published: 02 September 2009
